Intravenous Solutions Market
Intravenous Solutions Market Forecasts to 2030 - Global Analysis By Type (Total Parenteral Nutrition and Partial Parenteral Nutrition), Composition (Carbohydrates, Vitamins and Minerals, Parenteral Lipid Emulsion, Single Dose Amino Acids and Other Compositions), Solution Type, Bag Type, Application, End User and By Geography
|
Years Covered |
2021-2030 |
|
Estimated Year Value (2023) |
US $13.09 BN |
|
Projected Year Value (2030) |
US $25.5 BN |
|
CAGR (2023 - 2030) |
10.0% |
|
Regions Covered |
North America, Europe, Asia Pacific, South America, and Middle East & Africa |
|
Countries Covered |
US, Canada, Mexico, Germany, UK, Italy, France, Spain, Japan, China, India, Australia, New Zealand, South Korea, Rest of Asia Pacific, South America, Argentina, Brazil, Chile, Middle East & Africa, Saudi Arabia, UAE, Qatar, and South Africa |
|
Largest Market |
Europe |
|
Highest Growing Market |
Asia Pacific |
According to Stratistics MRC, the Global Intravenous Solutions Market is accounted for $13.09 billion in 2023 and is expected to reach $25.5 billion by 2030 growing at a CAGR of 10.0 % during the forecast period. Intravenous solutions, also called IV solutions, are sterile liquid treatments that are injected into a patient's veins by means of an intravenous line. These treatments are used for a variety of essential medical functions, such as rehydration, medicine delivery, and nutritional support, IV solutions are used to restore and maintain a patient's fluid and electrolyte balance, particularly when oral intake is insufficient or rapid absorption is required. They are composed of a precisely balanced blend of water, nutrients, and sometimes drugs and are a crucial part of contemporary healthcare, guaranteeing efficient treatment and patient support in a range of clinical settings, from hospitals to outpatient care, by supplying necessary fluids and medicinal chemicals straight into the bloodstream.
According to the guidelines by American Society for Parenteral and Enteral Nutrition (ASPEN), in 2020, the early parenteral nutrition should be initiated as soon as possible in the high-risk patient for whom early gastric enteral nutrition is not feasible.
Market Dynamics:
Driver:
New developments in IV solutions
As the developments involve the creation of specialized formulations with improved stability, solubility, and bioavailability. Additionally, modern ingredient technology makes it possible to create intravenous solutions that can transport a wider variety of therapeutic agents, such as complicated drugs and nutrients. As a result of these developments, it is now possible to treat a wider range of medical diseases by improving treatment efficacy and broadening the market's capacities. Therefore, the market for intravenous solutions benefits from being able to provide more sophisticated and specialized solutions, which enhance patient care and treatment outcomes and thus significantly drives the market growth.
Restraint:
High cost
IV solutions can be pricey, especially when made with complicated ingredients or in specialist formulations. Moreover, the price of manufacturing, packaging, and quality control can affect the overall cost of IV solutions. Hence, this pricing aspect may restrict market access, particularly in areas with limited resources or poor healthcare infrastructure.
Opportunity:
Increase in awareness
Preventive and holistic healthcare methods are in greater demand as people grow more health-conscious. Intravenous solutions are in demand not just for medical treatment but also for wellness and vitality reasons. They are frequently used for rehydration, immunological support, and nutrient supplementation. Furthermore, customized IV therapy is becoming more and more popular as a way to reduce deficiencies, increase energy, and improve general wellbeing. Moreover, clinics and providers offer intravenous solutions that meet the wellness and performance objectives of a health-conscious generation, which thus propel the market size.
Threat:
Lack of standardization and quality
The consistency of product performance and quality, which is essential for patient safety, might be hampered by varying quality and safety standards. Moreover, the absence of unified regulations across regions can lead to disparities in manufacturing practices and product labeling, making it challenging for healthcare providers to ensure the reliability of intravenous solutions. Therefore, this lack of standardization and regulatory oversight can result in increased risks and complexities in the market, emphasizing the need for comprehensive, globally recognized guidelines to ensure the safety and efficacy of these critical medical products.
Covid-19 Impact
The market for intravenous solutions was significantly negatively impacted by the COVID-19 epidemic. Healthcare facilities experienced rare resource pressures and were frequently overburdened, which resulted in shortages and logistical difficulties when locating and dispensing these vital medical fluids. Additionally, investments in the healthcare industry were impeded by the economic collapse and uncertainties. Therefore, despite rising demand, the pandemic posed logistical and financial challenges for the market for intravenous solutions, adversely impacting both accessibility and supply.
The Dextran segment is expected to be the largest during the forecast period
The Dextran segment is estimated to hold the largest share, as these treatments are used in healthcare facilities to boost blood flow and lower the chance of clot formation, primarily during operations and other medical procedures. Additionally, these IV solutions based on dextran, function as plasma expanders, enhancing circulation and assisting in blood pressure maintenance. They are crucial in circumstances where patients can experience bleeding or need hemodynamic support. Thus, intravenous solutions based on dextran are an essential part of the larger intravenous solutions market in the healthcare sector since they are essential in sustaining patient wellbeing during medical operations.
The large volume bags segment is expected to have the highest CAGR during the forecast period
The large volume bags segment is anticipated to have highest CAGR during the forecast period, due to a variety of uses in healthcare, such as nutrient delivery, medicine administration, and hydration, these bags are essential. Moreover, in hospitals, clinics, and other medical facilities, large-volume bags are frequently utilized to deliver effective and controlled intravenous therapy to patients. Hence, they are a backbone of the intravenous solutions market in the healthcare industry because they are flexible in accepting different types of solutions and are especially important for patients needing prolonged treatments.
Region with largest share:
Europe commanded the largest market share during the extrapolated period owing to the healthcare system's enormous patient population, the prominence of important players, the accessibility of drugs, the sophistication of the healthcare systems, and the advantageous reimbursement practices. Furthermore, the market for intravenous (IV) solutions in Europe will probably develop as a result of government support for the National Health Service and health insurance as well as industry technological advancements. Additionally, the intravenous solution market in the United Kingdom had the highest market share, while the intravenous solution market in France had the quickest rate of expansion in the continent of Europe.
Region with highest CAGR:
Asia Pacific is expected to witness highest CAGR over the projection period, owing to rapid growth, which can be attributed to the high investment made in research by both public and private entities, as well as technological developments and an increase in the number of cooperative relationships between different stakeholders, including the healthcare industry, universities, and others. Therefore, the rising prevalence of chronic diseases brought on by unhealthy food consumption patterns and the growing choice for cost-effective care are two significant factors that are projected to propel market growth in the Asia Pacific region.
Key players in the market
Some of the key players in the Intravenous Solutions Market include ICU Medical, Inc., B. Braun Melsungen Ag, JW Life Science, Baxter International Inc., Fresenius Kabi USA, LLC, Vifor Pharma Management Ltd, Amanta Healthcare, Grifols, S.A, Salius Pharma Private Limited., Pfizer, Inc., Axa Parenterals Ltd, Ajinomoto Co., Inc., Otsuka Pharmaceutical Co., Ltd, Sichuan Kelun Pharmaceutical Co Ltd, Soxa Formulations & Research Pvt. Ltd and Braun Melsungen AG.
Key Developments:
In March 2022, Otsuka Pharmaceutical received regulatory approval in Japan for the sale of SAMTASU intravenous infusion for treating cardiac edema.
In February 2022, B. Braun Medical received the US FDA approval to begin operations at its new IV saline solution manufacturing facility in Daytona Beach, Florida.
In September 2021, B. Braun Medical Inc. launched CARESAFE IV Administration Sets with an Optional AirStop component.
In July 2021, Grifols S.A. announced the establishment of an intravenous (IV) solutions production plant in Nigeria.
Types Covered:
• Total Parenteral Nutrition
• Partial Parenteral Nutrition
Compositions Covered:
• Carbohydrates
• Vitamins and Minerals
• Parenteral Lipid Emulsion
• Single Dose Amino Acids
• Other Compositions
Solution Types Covered:
• Dextran
• Saline
• Hypertonic Saline
• Amino Acid
• Normal Saline
• Lactated Ringer’s
• Heparin And Trace Elements
• Mixed Solutions
Bag Types Covered:
• Large Volume Bags
• Small Volume Bags
Applications Covered:
• Nutritional IV Solution
• Blood IV Solution
• Basic IV Solution
• Irrigation IV Solution
• Drug IV Solution
End Users Covered:
• Clinics
• Hospital
• Ambulatory Surgery Centers
• Home Care Settings
Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Table of Contents
1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Application Analysis
3.7 End User Analysis
3.8 Emerging Markets
3.9 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Intravenous Solutions Market, By Type
5.1 Introduction
5.2 Total Parenteral Nutrition
5.3 Partial Parenteral Nutrition
6 Global Intravenous Solutions Market, By Composition
6.1 Introduction
6.2 Carbohydrates
6.3 Vitamins and Minerals
6.4 Parenteral Lipid Emulsion
6.5 Single Dose Amino Acids
6.6 Other Compositions
7 Global Intravenous Solutions Market, By Solution Type
7.1 Introduction
7.2 Dextran
7.3 Saline
7.4 Hypertonic Saline
7.5 Amino Acid
7.6 Normal Saline
7.7 Lactated Ringer’s
7.8 Heparin And Trace Elements
7.9 Mixed Solutions
8 Global Intravenous Solutions Market, By Bag Type
8.1 Introduction
8.2 Large Volume Bags
8.3 Small Volume Bags
9 Global Intravenous Solutions Market, By Application
9.1 Introduction
9.2 Nutritional IV Solution
9.3 Blood IV Solution
9.4 Basic IV Solution
9.5 Irrigation IV Solution
9.6 Drug IV Solution
10 Global Intravenous Solutions Market, By End User
10.1 Introduction
10.2 Clinics
10.3 Hospital
10.4 Ambulatory Surgery Centers
10.5 Home Care Settings
11 Global Intravenous Solutions Market, By Geography
11.1 Introduction
11.2 North America
11.2.1 US
11.2.2 Canada
11.2.3 Mexico
11.3 Europe
11.3.1 Germany
11.3.2 UK
11.3.3 Italy
11.3.4 France
11.3.5 Spain
11.3.6 Rest of Europe
11.4 Asia Pacific
11.4.1 Japan
11.4.2 China
11.4.3 India
11.4.4 Australia
11.4.5 New Zealand
11.4.6 South Korea
11.4.7 Rest of Asia Pacific
11.5 South America
11.5.1 Argentina
11.5.2 Brazil
11.5.3 Chile
11.5.4 Rest of South America
11.6 Middle East & Africa
11.6.1 Saudi Arabia
11.6.2 UAE
11.6.3 Qatar
11.6.4 South Africa
11.6.5 Rest of Middle East & Africa
12 Key Developments
12.1 Agreements, Partnerships, Collaborations and Joint Ventures
12.2 Acquisitions & Mergers
12.3 New Product Launch
12.4 Expansions
12.5 Other Key Strategies
13 Company Profiling
13.1 ICU Medical, Inc.
13.2 B. Braun Melsungen Ag
13.3 JW Life Science
13.4 Baxter International Inc.
13.5 Fresenius Kabi USA, LLC
13.6 Vifor Pharma Management Ltd
13.7 Amanta Healthcare
13.8 Grifols, S.A
13.9 Salius Pharma Private Limited.
13.10 Pfizer, Inc.
13.11 Axa Parenterals Ltd
13.12 Ajinomoto Co., Inc.
13.13 Otsuka Pharmaceutical Co., Ltd
13.14 Sichuan Kelun Pharmaceutical Co Ltd
13.15 Soxa Formulations & Research Pvt. Ltd
13.16 Braun Melsungen AG
List of Tables
1 Global Intravenous Solutions Market Outlook, By Region (2021-2030) ($MN)
2 Global Intravenous Solutions Market Outlook, By Type (2021-2030) ($MN)
3 Global Intravenous Solutions Market Outlook, By Total Parenteral Nutrition (2021-2030) ($MN)
4 Global Intravenous Solutions Market Outlook, By Partial Parenteral Nutrition (2021-2030) ($MN)
5 Global Intravenous Solutions Market Outlook, By Composition (2021-2030) ($MN)
6 Global Intravenous Solutions Market Outlook, By Carbohydrates (2021-2030) ($MN)
7 Global Intravenous Solutions Market Outlook, By Vitamins And Minerals (2021-2030) ($MN)
8 Global Intravenous Solutions Market Outlook, By Parenteral Lipid Emulsion (2021-2030) ($MN)
9 Global Intravenous Solutions Market Outlook, By Single Dose Amino Acids (2021-2030) ($MN)
10 Global Intravenous Solutions Market Outlook, By Other Compositions (2021-2030) ($MN)
11 Global Intravenous Solutions Market Outlook, By Solution Type (2021-2030) ($MN)
12 Global Intravenous Solutions Market Outlook, By Dextran (2021-2030) ($MN)
13 Global Intravenous Solutions Market Outlook, By Saline (2021-2030) ($MN)
14 Global Intravenous Solutions Market Outlook, By Hypertonic Saline (2021-2030) ($MN)
15 Global Intravenous Solutions Market Outlook, By Amino Acid (2021-2030) ($MN)
16 Global Intravenous Solutions Market Outlook, By Normal Saline (2021-2030) ($MN)
17 Global Intravenous Solutions Market Outlook, By Lactated Ringer’s (2021-2030) ($MN)
18 Global Intravenous Solutions Market Outlook, By Heparin And Trace Elements (2021-2030) ($MN)
19 Global Intravenous Solutions Market Outlook, By Mixed Solutions (2021-2030) ($MN)
20 Global Intravenous Solutions Market Outlook, By Bag Type (2021-2030) ($MN)
21 Global Intravenous Solutions Market Outlook, By Large Volume Bags (2021-2030) ($MN)
22 Global Intravenous Solutions Market Outlook, By Small Volume Bags (2021-2030) ($MN)
23 Global Intravenous Solutions Market Outlook, By Application (2021-2030) ($MN)
24 Global Intravenous Solutions Market Outlook, By Nutritional IV Solution (2021-2030) ($MN)
25 Global Intravenous Solutions Market Outlook, By Blood IV Solution (2021-2030) ($MN)
26 Global Intravenous Solutions Market Outlook, By Basic IV Solution (2021-2030) ($MN)
27 Global Intravenous Solutions Market Outlook, By Irrigation IV Solution (2021-2030) ($MN)
28 Global Intravenous Solutions Market Outlook, By Drug IV Solution (2021-2030) ($MN)
29 Global Intravenous Solutions Market Outlook, By End User (2021-2030) ($MN)
30 Global Intravenous Solutions Market Outlook, By Clinics (2021-2030) ($MN)
31 Global Intravenous Solutions Market Outlook, By Hospital (2021-2030) ($MN)
32 Global Intravenous Solutions Market Outlook, By Ambulatory Surgery Centers (2021-2030) ($MN)
33 Global Intravenous Solutions Market Outlook, By Home Care Settings (2021-2030) ($MN)
Note: Tables For North America, Europe, APAC, South America, And Middle East & Africa Regions Are Also Represented In The Same Manner As Above.
List of Figures
List of Figures
Figure 1 Global Intravenous Solutions Market Outlook (2021-2030) ($MN)
Figure 2 North America Intravenous Solutions Market Outlook (2021-2030) ($MN)
Figure 3 US Intravenous Solutions Market Outlook (2021-2030) ($MN)
Figure 4 Canada Intravenous Solutions Market Outlook (2021-2030) ($MN)
Figure 5 Mexico Intravenous Solutions Market Outlook (2021-2030) ($MN)
Figure 6 Europe Intravenous Solutions Market Outlook (2021-2030) ($MN)
Figure 7 Germany Intravenous Solutions Market Outlook (2021-2030) ($MN)
Figure 8 UK Intravenous Solutions Market Outlook (2021-2030) ($MN)
Figure 9 Italy Intravenous Solutions Market Outlook (2021-2030) ($MN)
Figure 10 France Intravenous Solutions Market Outlook (2021-2030) ($MN)
Figure 11 Spain Intravenous Solutions Market Outlook (2021-2030) ($MN)
Figure 12 Rest of Europe Intravenous Solutions Market Outlook (2021-2030) ($MN)
Figure 13 Asia Pacific Intravenous Solutions Market Outlook (2021-2030) ($MN)
Figure 14 Japan Intravenous Solutions Market Outlook (2021-2030) ($MN)
Figure 15 China Intravenous Solutions Market Outlook (2021-2030) ($MN)
Figure 16 India Intravenous Solutions Market Outlook (2021-2030) ($MN)
Figure 17 Australia Intravenous Solutions Market Outlook (2021-2030) ($MN)
Figure 18 New Zealand Intravenous Solutions Market Outlook (2021-2030) ($MN)
Figure 19 South Korea Intravenous Solutions Market Outlook (2021-2030) ($MN)
Figure 20 Rest of Asia Pacific Intravenous Solutions Market Outlook (2021-2030) ($MN)
Figure 21 South America Intravenous Solutions Market Outlook (2021-2030) ($MN)
Figure 22 Argentina Intravenous Solutions Market Outlook (2021-2030) ($MN)
Figure 23 Brazil Intravenous Solutions Market Outlook (2021-2030) ($MN)
Figure 24 Chile Intravenous Solutions Market Outlook (2021-2030) ($MN)
Figure 25 Rest of South America Intravenous Solutions Market Outlook (2021-2030) ($MN)
Figure 26 Middle East & Africa Intravenous Solutions Market Outlook (2021-2030) ($MN)
Figure 27 Saudi Arabia Intravenous Solutions Market Outlook (2021-2030) ($MN)
Figure 28 UAE Intravenous Solutions Market Outlook (2021-2030) ($MN)
Figure 29 Qatar Intravenous Solutions Market Outlook (2021-2030) ($MN)
Figure 30 South Africa Intravenous Solutions Market Outlook (2021-2030) ($MN)
Figure 31 Rest of Middle East & Africa Intravenous Solutions Market Outlook (2021-2030) ($MN)
RESEARCH METHODOLOGY
We at ‘Stratistics’ opt for an extensive research approach which involves data mining, data validation, and data analysis. The various research sources include in-house repository, secondary research, competitor’s sources, social media research, client internal data, and primary research.
Our team of analysts prefers the most reliable and authenticated data sources in order to perform the comprehensive literature search. With access to most of the authenticated data bases our team highly considers the best mix of information through various sources to obtain extensive and accurate analysis.
Each report takes an average time of a month and a team of 4 industry analysts. The time may vary depending on the scope and data availability of the desired market report. The various parameters used in the market assessment are standardized in order to enhance the data accuracy.
Data Mining
The data is collected from several authenticated, reliable, paid and unpaid sources and is filtered depending on the scope & objective of the research. Our reports repository acts as an added advantage in this procedure. Data gathering from the raw material suppliers, distributors and the manufacturers is performed on a regular basis, this helps in the comprehensive understanding of the products value chain. Apart from the above mentioned sources the data is also collected from the industry consultants to ensure the objective of the study is in the right direction.
Market trends such as technological advancements, regulatory affairs, market dynamics (Drivers, Restraints, Opportunities and Challenges) are obtained from scientific journals, market related national & international associations and organizations.
Data Analysis
From the data that is collected depending on the scope & objective of the research the data is subjected for the analysis. The critical steps that we follow for the data analysis include:
- Product Lifecycle Analysis
- Competitor analysis
- Risk analysis
- Porters Analysis
- PESTEL Analysis
- SWOT Analysis
The data engineering is performed by the core industry experts considering both the Marketing Mix Modeling and the Demand Forecasting. The marketing mix modeling makes use of multiple-regression techniques to predict the optimal mix of marketing variables. Regression factor is based on a number of variables and how they relate to an outcome such as sales or profits.
Data Validation
The data validation is performed by the exhaustive primary research from the expert interviews. This includes telephonic interviews, focus groups, face to face interviews, and questionnaires to validate our research from all aspects. The industry experts we approach come from the leading firms, involved in the supply chain ranging from the suppliers, distributors to the manufacturers and consumers so as to ensure an unbiased analysis.
We are in touch with more than 15,000 industry experts with the right mix of consultants, CEO's, presidents, vice presidents, managers, experts from both supply side and demand side, executives and so on.
The data validation involves the primary research from the industry experts belonging to:
- Leading Companies
- Suppliers & Distributors
- Manufacturers
- Consumers
- Industry/Strategic Consultants
Apart from the data validation the primary research also helps in performing the fill gap research, i.e. providing solutions for the unmet needs of the research which helps in enhancing the reports quality.
For more details about research methodology, kindly write to us at info@strategymrc.com
Frequently Asked Questions
In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.
Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.
All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
We have 3 different licensing options available in electronic format.
- Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
- 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
- Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.
All our reports are typically be emailed to you as an attachment.
To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.
We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.
Request Customization
We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.
WHY CHOOSE US ?
Assured Quality
Best in class reports with high standard of research integrity
24X7 Research Support
Continuous support to ensure the best customer experience.
Free Customization
Adding more values to your product of interest.
Safe & Secure Access
Providing a secured environment for all online transactions.
Trusted by 600+ Brands
Serving the most reputed brands across the world.
